STOCK TITAN

USANA (NYSE: USNA) CFO sells 5,360 Common Stock shares in market trade

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

USANA Health Sciences' Chief Financial Officer, Doug G. IIEKKING, reported selling 5,360 shares of the company’s Common Stock in an open-market transaction. The sale occurred at an average price of $18.7525 per share. Following this transaction, his directly held Common Stock position reported in this filing is zero shares.

Positive

  • None.

Negative

  • None.
Insider IIEKKING G DOUG
Role CHIEF FINANCIAL OFFICER
Sold 5,360 shs ($101K)
Type Security Shares Price Value
Sale Common Stock 5,360 $18.7525 $101K
Holdings After Transaction: Common Stock — 0 shares (Direct)
Shares sold 5,360 shares Common Stock sold by CFO on 2026-05-27
Sale price per share $18.7525 per share Average price for the reported open-market sale
Shares after transaction 0 shares Directly held Common Stock by CFO following the sale
Net share direction -5,360 shares Net buy/sell shares in this Form 4
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
transaction code "S" financial
""transaction_code": "S""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did USANA (USNA) disclose in this Form 4?

USANA reported that its Chief Financial Officer, Doug G. IIEKKING, sold 5,360 shares of Common Stock in an open-market transaction at an average price of $18.7525 per share, according to a Form 4 insider filing.

How many USANA (USNA) shares did the CFO sell and at what price?

The CFO sold 5,360 shares of USANA Common Stock at an average price of $18.7525 per share. This was reported as a sale in the open market or a private transaction under transaction code “S.”

What are the CFO’s USANA (USNA) holdings after this reported sale?

After the reported transaction, the Form 4 shows the Chief Financial Officer with total directly owned Common Stock holdings of zero shares. The filing does not list any remaining derivative positions for this reporting person.

Was the USANA (USNA) CFO transaction a buy or sell according to the Form 4?

The Form 4 classifies the transaction as a sell. It identifies a transaction code “S” and describes it as an open-market or private sale of Common Stock totaling 5,360 shares at an average price of $18.7525 per share.

Did the USANA (USNA) Form 4 report any option exercises or derivatives for the CFO?

The Form 4 shows no derivative transactions or option exercises for the CFO in this filing. The derivative summary section is empty, and the only reported activity is the sale of 5,360 shares of Common Stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
IIEKKING G DOUG

(Last)(First)(Middle)
3838 WEST PARKWAY BLVD

(Street)
SALT LAKE CITY UTAH 84120

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/27/2026S5,360D$18.75250D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)